56
Views
3
CrossRef citations to date
0
Altmetric
Key Paper Evaluation

Telcagepant is a new oral treatment for migraine

Evaluation of Ho TW, Ferrari MD, Rodick DW et al. Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomized, placebo-controlled, parallel-treatment trial. The Lancet 2008;372:2115-2123

, PhD DSc
Pages 1523-1526 | Published online: 08 Jun 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Daniel V Paone & Donnette D Staas. (2009) Calcitonin gene-related peptide receptor antagonists for the treatment of migraine: a patent review. Expert Opinion on Therapeutic Patents 19:12, pages 1675-1713.
Read now

Articles from other publishers (2)

Nazia Karsan, Jonathan Jia Yuan Ong & Peter Goadsby. (2018) Emerging Treatment Options in Migraine. EMJ Neurology, pages 50-58.
Crossref
Jason A. Smith, Peter P. Molesworth, Christopher J.T. Hyland & John H. Ryan. 2011. 491 536 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.